SB
Satheesh Bhonagiri
About Satheesh Bhonagiri
Data last updated:
Satheesh Bhonagiri is a Director at Medicon Therapeutics Private Limited (since 2020) and Director at Kanberry Infra Private Limited (since 2022). The companies operate in Trading and Construction. The largest current company by reported revenue is Medicon Therapeutics Private Limited at ₹35 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 13 Jun 2020 | 2020 | ₹35 Lakh (FY 2025) | Active | |
| Director | 15 Dec 2022 | 2022 | Active |
Board colleagues of Satheesh Bhonagiri
| Name | DIN | Company | Designation |
|---|---|---|---|
| Madhavi Aluri | 11100941 | Medicon Therapeutics Private Limited | Director |
| Ujwala Birru | 11306318 | Medicon Therapeutics Private Limited | Director |
| Keshmoni Ramesh Goud | 09826025 | Kanberry Infra Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Satheesh Bhonagiri
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Satheesh Bhonagiri
Satheesh Bhonagiri currently holds 2 directorships: Medicon Therapeutics Private Limited (Director, since 13 Jun 2020, revenue ₹35 Lakh (FY 2025)); Kanberry Infra Private Limited (Director, since 15 Dec 2022).
Satheesh Bhonagiri was first appointed on 13 Jun 2020 as Director at Medicon Therapeutics Private Limited. The most recent appointment on record is 15 Dec 2022 at Kanberry Infra Private Limited.
The current boards of Satheesh Bhonagiri's companies include Madhavi Aluri (Medicon Therapeutics Private Limited), Ujwala Birru (Medicon Therapeutics Private Limited), Keshmoni Ramesh Goud (Kanberry Infra Private Limited).